» Articles » PMID: 12761036

Upregulation of the Rac1/JNK Signaling Pathway in Primary Human Schwannoma Cells

Overview
Journal Hum Mol Genet
Date 2003 May 23
PMID 12761036
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Schwann cells lacking the tumor-suppressor-protein merlin tend in man to build benign tumors (schwannoma). We observed that characteristic features of these cells which are relevant to tumorigenicity resemble those described in cells with high Rac activity. Moreover this small GTPase also phosphorylates merlin via PAK activation. We hypothesized that merlin deficiency might cause an activation of Rac and its dependent signaling pathways, in particular the pro-tumorigenic JNK pathway. We show an enhanced activation of Rac1 in primary human schwannoma cells, find both Rac and its effector PAK at the membrane where they colocalize, and describe increased levels of phosphorylated JNK in the nucleus of these cells. Further we describe regulation at post-transcriptional level with upregulated protein, but not mRNA levels for Rac1, and JNK1/2. We conclude that merlin regulates Rac activation, and suggest that this is important for human schwannoma cell dedifferentiation.

Citing Articles

Modulating PAK1: Accessory Proteins as Promising Therapeutic Targets.

Mirzaiebadizi A, Shafabakhsh R, Ahmadian M Biomolecules. 2025; 15(2).

PMID: 40001545 PMC: 11852631. DOI: 10.3390/biom15020242.


Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state.

Barrett T, Patel B, Khan S, Mullins R, Yim A, Pugazenthi S Nat Commun. 2024; 15(1):478.

PMID: 38216553 PMC: 10786875. DOI: 10.1038/s41467-023-42762-w.


Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801.

Dougherty M, Shibata S, Clark J, Canady F, Yates C, Hansen M J Neurosurg. 2022; 138(4):962-971.

PMID: 36087315 PMC: 10193498. DOI: 10.3171/2022.7.JNS22934.


Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects.

Zhang Y, Long J, Ren J, Huang X, Zhong P, Wang B Front Oncol. 2021; 11:731441.

PMID: 34646772 PMC: 8503266. DOI: 10.3389/fonc.2021.731441.


The biological underpinnings of radiation therapy for vestibular schwannomas: Review of the literature.

Dougherty M, Shibata S, Hansen M Laryngoscope Investig Otolaryngol. 2021; 6(3):458-468.

PMID: 34195368 PMC: 8223465. DOI: 10.1002/lio2.553.